Public procurement notice: Contract Notice
Published: 2016-10-21
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Region: SCOTLAND
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33693200
Estimated value: 21300000 GBP
Submission deadline: 2016-11-18
Award criteria: The most economic tender

Technical requirements: Potential Framework Participants will also be invited to offer rebates against NHS list price where these products are supplied in the community and prisons under the current prescribing mechanisms.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Framework Agreement is for the supply of Nicotine Replacement Therapy Products to Health Boards across NHS Scotland and for use in community and prison settings.
The framework agreement will be awarded as a unranked multi-supplier framework to a maximum of six (6) suppliers for the total requirement.
The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) Potential Framework Participants and any sub-contractor(s) must possess a UKAS (or equivalent) accredited independent third party certificate of compliance with BS EN ISO 14001 (or equivalent) or a valid EMAS (or equivalent) certificate.
(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.
(b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes.
(c) Confirmation of the existence of certificates drawn up by independent bodies attesting the compliance with the required environmental management systems or standards should be included in the Qualification Envelope of the ITT under Environmental Management Standards.
The estimated value range referred to in Sections II.1.5) and II.2.6) covers the twenty four (24) months initial duration and the full two (2) periods of twelve (12) month extension options.
The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 6887. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343
The Contracting Authority does not intend to include a sub-contract clause in this contract for the following reason:

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 21300000